Marco A Zarbin1. Show Affiliations » 1. New Jersey Medical School, Institute of Ophthalmology and Visual Science, Newark.
Abstract
Entities: Disease
Mesh： See more » Alkylating Agents/therapeutic useApoptosis/drug effectsCalcium Channel Blockers/therapeutic useCicatrix/drug therapyCicatrix/etiologyConjunctival Diseases/drug therapyConjunctival Diseases/etiologyCyclosporine/therapeutic useDrug Therapy, CombinationEnzyme Inhibitors/therapeutic useFibroblasts/pathologyFiltering SurgeryGlaucoma/surgeryHumansMitomycin/therapeutic usePostoperative ComplicationsStaurosporine/therapeutic useTenon Capsule/drug effectsVerapamil/therapeutic use
Substances： See more » Alkylating AgentsCalcium Channel BlockersEnzyme InhibitorsMitomycinCyclosporineVerapamilStaurosporine
Year: 2013 PMID： 23846673 DOI： 10.1001/jamaophthalmol.2013.5575
Source DB: PubMed Journal: JAMA Ophthalmol ISSN： 2168-6165 Impact factor: 7.389